L2M – SenseOn-Pro

SenseOn-Pro is a small wearable fingertip device that uses photoplethysmogram (PPG) sensor data combined with advanced algorithms to measure many different health markers and events simultaneously. It enables non-invasive, continuous monitoring of multiple chronic health conditions. The device allows the assessment of blood glucose without the need for blood pricking, which is an important component of diabetes management. It is able to monitor cardiovascular disease (CVD) without the use of electrodes, as well as detecting Obstructive Sleep Apnea (OSA) events that would otherwise go undetected. The ability for the device to perform these functions in combination with the general health markers it can identify, such as blood oxygen, and blood pressure grants users a crucial holistic insight into their well-being.
The need for this device in the current landscape stems from the severity of these chronic conditions in Canada. CVD is among the top causes of death in Canada with over 2.5 million Canadians suffering from a diagnosed heart disease. It claims about 14 lives every single hour. Diabetes affects nearly 1 in 10 Canadians over the age of 20 and yet only half of Canadians diagnosed with diabetes meet optimal blood glucose targets, which can result in various serious complications, such as blindness, kidney failure, stroke or even amputation. OSA is very prevalent condition with estimated 28% of Canadians suffering from moderate to severe OSA, and approximately 93% of people at high risk of OSA were undiagnosed. Having effective means of monitoring and diagnosing these conditions is critical in mitigating their harms.

Faculty Supervisor:

Vijay Mago

Student:

Partner:

DMZ Ventures Inc

Discipline:

Engineering

Sector:

Technology; Artificial Intelligence; Health and Related Sciences & Technology

University:

York University

Program: